Chondroitin Sulfate as a Lysosomal Enhancer Attenuates Lipid-Driven Inflammation via Lipophagy and Mitophagy

Non-alcoholic steatohepatitis (NASH), a progressive liver disease characterized by lipid accumulation and chronic inflammation, lacks effective therapies targeting its multifactorial pathogenesis. This study investigates marine-derived chondroitin sulfate (CS) as a multi-organelle modulator capable...

Full description

Bibliographic Details

Published in:	Marine Drugs
Main Authors:	Ting Sun, Huimin Lv, Huarong Shao, Xiuhua Zhang, Anqi Wang, Wei Zhang, Fei Liu, Peixue Ling
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Subjects:	non-alcoholic steatohepatitis chondroitin sulfate subcellular regulation lysosomal acidification lipid metabolism mitochondrial autophagy
Online Access:	https://www.mdpi.com/1660-3397/23/6/228